Sign In
Buy SPOK
$10.90
+0.150 (+1.40%)
At Close: Jul 31, 2026
Spok Sets Date to Report Fourth Quarter and Full Year 2025 Results
11:43am, Wednesday, 18'th Feb 2026
PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced it will release its fourth quarter and full year 2025 operating results
Spok Earns Top Client Satisfaction Scores for Ninth Consecutive Year
08:30am, Wednesday, 04'th Feb 2026
PLANO, Texas--(BUSINESS WIRE)--Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a leader in healthcare communications, achieved the top honors for the ninth consecutive
Is the Options Market Predicting a Spike in Spok Stock?
10:01am, Tuesday, 23'rd Dec 2025
Investors need to pay close attention to SPOK stock based on the movements in the options market lately.
Reviewing Spok (NASDAQ:SPOK) and Liberty Latin America (NASDAQ:LILA)
02:14am, Sunday, 07'th Dec 2025
Liberty Latin America (NASDAQ: LILA - Get Free Report) and Spok (NASDAQ: SPOK - Get Free Report) are both small-cap computer and technology companies, but which is the superior stock? We will contrast
15th Annual Spok Survey Highlights Shifting Clinical Communication Opportunities and Obstacles
08:30am, Wednesday, 12'th Nov 2025
PLANO, Texas--(BUSINESS WIRE)--Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, released the results of its 15th annual sur
Spok Holdings, Inc. (SPOK) Q2 2025 Earnings Call Transcript
07:16pm, Wednesday, 29'th Oct 2025
Spok Holdings, Inc. ( SPOK ) Q2 2025 Earnings Call October 29, 2025 5:00 PM EDT Company Participants Al Galgano - Investor Relations Contact Vincent Kelly - President, CEO & Director Michael Wallace -
Spok Holdings (SPOK) Q3 Earnings and Revenues Miss Estimates
06:51pm, Wednesday, 29'th Oct 2025
Spok Holdings (SPOK) came out with quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.18 per share a year ago.
Spok Reports Third Quarter 2025 Results
04:05pm, Wednesday, 29'th Oct 2025
PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the third quarter ended September 30, 2025. In addition, th
Spok Sets Date to Report Third Quarter 2025 Results
10:30am, Wednesday, 22'nd Oct 2025
PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced it will release its third quarter 2025 operating results on Wednesday,
U.S. News & World Report Names Spok-Powered Hospitals to Best Children's Hospitals Honor Roll
08:30am, Thursday, 09'th Oct 2025
PLANO, Texas--(BUSINESS WIRE)--Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, is privileged to recognize that nine of the
Here's Why Spok Holdings (SPOK) is a Great Momentum Stock to Buy
01:01pm, Tuesday, 05'th Aug 2025
Does Spok Holdings (SPOK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Spok-Powered Hospitals Achieve Recognition on U.S. News & World Report's Best Hospitals Honor Roll
08:30am, Tuesday, 05'th Aug 2025
PLANO, Texas--(BUSINESS WIRE)--Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, today reported that 18 of the 20 adult hosp
3 Healthcare Stocks Paying the Highest Dividends of 2025
05:50am, Tuesday, 05'th Aug 2025
The healthcare sector has long been a favorite for income investors -- and for good reason. Many healthcare stocks offer attractive dividend yields.
3 Reasons Growth Investors Will Love Spok (SPOK)
01:46pm, Monday, 04'th Aug 2025
Spok (SPOK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
All You Need to Know About Spok (SPOK) Rating Upgrade to Buy
01:00pm, Friday, 01'st Aug 2025
Spok (SPOK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
